A Clinical Pharmacological Study of OPC-41061 [tolvaptan] in the Treatment of Cardiac Edema (Congestive Heart Failure).
Phase of Trial: Phase III
Latest Information Update: 19 May 2016
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Registrational
- Sponsors Otsuka Pharmaceutical
- 16 Dec 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History